An expired patent — previously held by Vanguard — may spark a shake-up in the exchange-traded fund industry. Wall Street saw the patent as critical to Vanguard's success because it saved an enormous ...

Eric J. Fues and Kyle W. Howarth of Finnegan address the on-sale bar in patent law, with a focus on how pre-filing sales of ...

Samsung may be getting ready to flip the script on foldable phones, literally. A newly approved patent from the United States ...

Ian King believes DOGE's next big move could be bringing AI to the U.S. Patent Office. Here’s why that should matter to ...

The United States patent system underwent a significant change with the enactment of the First-Inventor-to-File (FITF) ...

As a patent trial lawyer and IP attorney, one question clients frequently ask is, “Why should we build a patent portfolio?” ...

DeepIP, the AI-powered patent assistant, has secured $15 million in Series A funding to modernize the outdated patent filing ...

CureVac N.V. secured funding with GSK amid financial struggles, while a key patent win boosts stock. Click for why my ...

David McCombs, Eugene Goryunov and Jonathan Bowser of Haynes Boone discuss collateral estoppel and when it might apply in a ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in ...

GM has filed a patent application for a context-based reminder system for vehicles, potentially providing custom prompts ...